Holen Sie sich die Stockscreener-App
247.05
0.04%
-0.21
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$247.26
Offen:
$248.83
24-Stunden-Volumen:
295.75K
Relative Volume:
0.16
Marktkapitalisierung:
$29.84B
Einnahmen:
$117.76B
Nettoeinkommen (Verlust:
$1.21B
KGV:
24.83
EPS:
9.95
Netto-Cashflow:
$2.39B
1W Leistung:
+6.75%
1M Leistung:
+3.12%
6M Leistung:
-16.37%
1J Leistung:
-32.03%
1-Tages-Spanne:
$245.93
$250.66
1-Wochen-Bereich:
$227.51
$265.25
52-Wochen-Spanne:
$206.87
$382.72
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Vergleichen Sie HUM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
247.21 | 29.74B | 117.76B | 1.21B | 2.39B | 9.95 |
|
UNH
Unitedhealth Group Inc
|
239.74 | 215.69B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
62.16 | 79.23B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
264.93 | 70.00B | 261.22B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
279.01 | 61.85B | 189.25B | 5.36B | 5.34B | 23.50 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Vestcor Inc Cuts Stake in Humana Inc. (NYSE:HUM) - MarketBeat
1,674 Shares in Humana Inc. (NYSE:HUM) Bought by Private Advisor Group LLC - MarketBeat
How volatile is Humana Inc. stock compared to the marketCapitalize on momentum-driven opportunities - jammulinksnews.com
Natixis Advisors LLC Has $28.91 Million Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
How many analysts rate Humana Inc. as a “Buy”Unlock powerful stock screening for profits - jammulinksnews.com
What are the latest earnings results for Humana Inc.Free Trading Psychology Coaching - jammulinksnews.com
Wall Street Zen Downgrades Humana (NYSE:HUM) to Hold - MarketBeat
National Senior Games 2025Humana Game Changers - Goshen News
Federated Hermes Inc. Has $22.04 Million Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
FY2025 EPS Estimates for Humana Boosted by Leerink Partnrs - MarketBeat
Humana Inc. (NYSE:HUM) Shares Purchased by Meeder Asset Management Inc. - MarketBeat
Morgan Stanley Lowers Humana (NYSE:HUM) Price Target to $277.00 - MarketBeat
Piper Sandler Cuts Humana (NYSE:HUM) Price Target to $272.00 - MarketBeat
Why Humana (HUM) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Howard Capital Management Inc. Reduces Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Insurer Humana raises annual profit forecast as medical costs stabilize - MSN
TD Asset Management Inc Sells 2,387 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Exact Sciences expands partnership with Humana to improve colorectal cancer screening - Yahoo Finance
High Ground Investment Management LLP Buys 6,095 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Q2 2025 Earnings Call Transcript - MSN
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength? - MSN
Skandinaviska Enskilda Banken AB publ Grows Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Texas Yale Capital Corp. Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana (NYSE:HUM) Shares Gap UpWhat's Next? - MarketBeat
Humana (HUM) Target Price Lowered by Morgan Stanley | HUM Stock News - GuruFocus
Humana (HUM) Target Price Reduced by Piper Sandler - GuruFocus
Piper Sandler Lowers Price Target for Humana (HUM) to $272 | HUM Stock News - GuruFocus
Humana price target lowered to $272 from $288 at Piper Sandler - TipRanks
8,732 Shares in Humana Inc. (NYSE:HUM) Purchased by Bellwether Advisors LLC - MarketBeat
Humana Inc. (NYSE:HUM) Shares Acquired by Bayforest Capital Ltd - MarketBeat
Humana reports lower Q2 earnings - Insurance Business America
Banque Cantonale Vaudoise Takes Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Revises Profit Outlook as Medicare Costs Find Stability - IndiaMedToday
Exact Sciences, Humana partner to offer Cologuard Plus in-network By Investing.com - Investing.com Canada
Exact Sciences, Humana partner to offer Cologuard Plus in-network - Investing.com Australia
Humana (NYSE:HUM) Releases FY 2025 Earnings Guidance - MarketBeat
Exact Sciences expands Humana partnership for colorectal cancer screening - StreetInsider
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test - Business Wire
Humana (HUM) Jumps 12.4% on Higher Revenues, Growth Outlook - MSN
Humana Inc. (NYSE:HUM) Shares Sold by Pacer Advisors Inc. - MarketBeat
Humana Inc (HUM) Q2 2025 Earnings Call Highlights: Strong EPS Ou - GuruFocus
Humana Inc (HUM) Q2 2025 Earnings Call Highlights: Strong EPS Outlook and Strategic Growth Initiatives - GuruFocus
Humana Inc. Reports Strong Q2 2025 Earnings and Raises Guidance - TipRanks
Humana’s Earnings Call: Positive Outlook Amid Challenges - TipRanks
Humana's early retirement offering to some employees raises concern for local economist - WDRB
Neal-Clinton: 2025 Annual Enrollment Update On Humana, UnitedHealthcare & Aetna - Los Alamos Daily Post
Humana outperforms on MA, raises guidance - Healthcare Finance News
Humana, SoFi, LendingClub, Generac, Palo Alto, Teradyne, Harley-Davidson, Peloton, and More Movers - Barron's
EXCLUSIVE: Humana to offer employees a buyout in form of early retirement option - The Courier-Journal
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):